文献速递高血压冠心病

高血压伴左心室肥厚患者的治疗中血压与心血管结局

On-Treatment Blood Pressure and Cardiovascular Outcomes in Adults With Hypertension and Left Ventricular Hypertrophy.
PubMed 文献 · J Am Coll Cardiol · 2021-01-01

基于全国健康检查数据库的回顾性队列研究,纳入95,545例40-79岁正在服用降压药且基线心电图提示左心室肥厚的患者,中位随访11.5年。结果显示治疗中收缩压<130 mmHg和舒张压<80 mmHg时心血管事件风险最低,收缩压120-129 mmHg组风险最低,≥140 mmHg组风险显著升高。

要点

  • 高血压伴左心室肥厚患者治疗中收缩压<130 mmHg、舒张压<80 mmHg时心血管事件风险最低
  • 收缩压≥140 mmHg者心血管事件风险较120-129 mmHg组升高31%
  • 舒张压≥90 mmHg者心血管事件风险较70-79 mmHg组升高30%

核心结论

  • 在高血压伴左心室肥厚的成人中,治疗中收缩压<130 mmHg和舒张压<80 mmHg时心血管事件风险最低。
  • 需要进一步随机试验以确定该类患者的最佳降压策略。

研究设计与样本

  • 来自全国健康检查数据库的回顾性队列研究,纳入95,545例40-79岁正在服用降压药且基线心电图提示左心室肥厚的参与者。
  • 使用Cox模型计算收缩压或舒张压对应的心血管事件HR和95%CI。

主要发现

  • 中位随访11.5年,发生12,035例新发心血管事件。
  • 立方样条模型显示收缩压<130 mmHg和舒张压<80 mmHg与心血管事件风险最低相关。
  • 以收缩压120-129 mmHg组为参照,多变量校正HR在≥140 mmHg组为1.31(95%CI:1.24-1.38),130-139 mmHg组为1.08(95%CI:1.02-1.15),<120 mmHg组为1.03(95%CI:0.93-1.15)。
  • 以舒张压70-79 mmHg组为参照,多变量校正HR在≥90 mmHg组为1.30(95%CI:1.24-1.37),80-89 mmHg组为1.06(95%CI:1.01-1.12),<70 mmHg组为1.08(95%CI:0.96-1.20)。

临床怎么用

  • 对高血压伴左心室肥厚患者,治疗中可考虑将收缩压控制在<130 mmHg、舒张压控制在<80 mmHg以降低心血管事件风险。
  • 收缩压≥140 mmHg或舒张压≥90 mmHg时心血管风险显著升高,应加强降压管理。

局限性

  • 研究为回顾性队列设计,无法确立因果关系。
  • 左心室肥厚基于基线心电图诊断,可能存在漏诊或误诊。
  • 结论需进一步随机试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Benefits of intensive blood pressure lowering on health outcomes have been demonstrated in high-risk patients. However, little is known about such benefits in patients with left ventricular hypertrophy (LVH). OBJECTIVES: This study sought to investigate the association of on-treatment blood pressure with cardiovascular disease (CVD) risk in adults with hypertension and LVH. METHODS: From a nationwide health examination database, this study identified 95,545 participants aged 40-79 years who were taking antihypertensive medication and had LVH on baseline electrocardiography. Using Cox models, HRs and 95% CIs for CVD events were calculated according to systolic blood pressure (SBP) or diastolic blood pressure (DBP). RESULTS: Over a median follow-up of 11.5 years, 12,035 new CVD events occurred. An SBP of <130 mm Hg and DBP of <80 mm Hg were associated with the lowest risk for CVD events in cubic spline models. When the group with SBP of 120-129 mm Hg was the reference, multivariable-adjusted HRs were 1.31 (95% CI: 1.24-1.38) in the ≥140 mm Hg group, 1.08 (95% CI: 1.02-1.15) in the 130-139 mm Hg group, and 1.03 (95% CI: 0.93-1.15) in the <120 mm Hg group. Likewise, when the group with DBP of 70-79 mm Hg was the reference, multivariable-adjusted HRs were 1.30 (95% CI: 1.24-1.37) in the ≥90 mm Hg group, 1.06 (95% CI: 1.01-1.12) in the 80-89 mm Hg group, and 1.08 (95% CI: 0.96 to 1.20) in the <70 mm Hg group. CONCLUSIONS: In adults with hypertension and LVH, the risk for CVD events was the lowest at SBP <130 mm Hg and DBP <80 mm Hg. Further randomized trials are warranted to establish optimal blood pressure-lowering strategies for these patients.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Lee HH, Lee H, Cho SMJ, et al. On-Treatment Blood Pressure and Cardiovascular Outcomes in Adults With Hypertension and Left Ventricular Hypertrophy. J Am Coll Cardiol. 2021. PMID: 34620404. doi:10.1016/j.jacc.2021.08.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。